Calidi Biotherapeutics share price logo

Calidi Biotherapeutics

AMEX: CLDI

$1.05

-0.03

(-2.78%)

as on

Calidi Biotherapeutics Stock Performance

as on October 6, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $1.00
    $1.12
    downward going graph

    4.76%

    Downside

    6.67%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.00
    $27.84
    downward going graph

    4.76%

    Downside

    2551.43%

    Upside

    downward going graph

Calidi Biotherapeutics share price movements today

Previous Close
$1.08
Open
$1.04
Volume
84.7K
Market Cap
$2.8M
Day's Low - High
$1.00 - $1.12
52 Week Low - High
$1.00 - $27.84

Calidi Biotherapeutics Historical Returns

1 Month Return
-24.19 %
3 Month Return
-56.31 %
1 Year Return
-95.79 %
3 Year Return
-99.98 %
5 Year Return
0 %

Calidi Biotherapeutics Stock Fundamentals & Key Indicators

Check Calidi Biotherapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.8M

EPS (TTM)

-54.14

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.02

Industry PE ratio

-2.34

PEG Ratio

-0.00

EBITDA

-16.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-372.86%

Calidi Biotherapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Calidi Biotherapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$2.8MNA-0.020.00%0.00%
StrongBuy$44.3B650.56%-23.320.00%0.00%
Neutral$75.9B-32.81%-23.81-12.57%0.00%
StrongBuy$127.9B178.32%29.1486.04%0.00%
Buy$75.7B32.91%17.5584.86%0.50%

Stock Returns calculator for Calidi Biotherapeutics Stock including INR - Dollar returns

The Calidi Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Calidi Biotherapeutics investment value today

Current value as on today

₹4,566

Returns

-₹95,434

(-95.43%)

Returns from Calidi Biotherapeutics Stock

-₹95,793 (-95.79%)

Dollar Impact

₹359 (+0.36%)

Analyst Recommendation on Calidi Biotherapeutics Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Calidi Biotherapeutics. Average target price of $120

Calidi Biotherapeutics Share Price Target

Get share price movements and forecasts by analysts on Calidi Biotherapeutics.

What analysts predicted

99.13%UPSIDE

Target Price

$120

Current Price

$1.05

Analyzed by

8 Analysts

Target

$120.00

Calidi Biotherapeutics target price $120, a slight upside of 99.13% compared to current price of $1.05. According to 8 analysts rating.

Indian Investors' Interest in Calidi Biotherapeutics Stock

Search interest for Calidi Biotherapeutics Stock has decreased by -37% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-37% versus previous 30 day period

Calidi Biotherapeutics Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
-
-
-
-
-
-
0
-
Operating Income
-9
-6
-5
-5
-5
-5
-5
-4
-4
-4
EBITDA
-7
-6
-5
-4
-4
-5
-4
-3
-3
-4
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-8
-7
-5
-5
-5
-5
-5
-4
-4
-4
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-8
-7
-5
-5
-4
-5
-5
-4
-4
-4
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Calidi Biotherapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Mar 2025
Dec 2025
Total Revenue
-
0
0
-
-
-
Gross Profit
-
0
0
-1
-
-1
Operating Income
-6
-10
-23
-28
-21
-20
EBITDA
-6
-9
-24
-24
-19
-18
Interest Expense
0
0
0
3
0
0
Depreciation
0
0
0
1
1
1
Income Before Tax
-7
3
-25
-29
-22
-20
Income Tax Expense
0
0
0
0
0
0
Net Income
-7
-10
-25
-29
-22
-19
Net Profit Margin
0.00%
79.06%
-508.89%
0.00%
0.00%
0.00%

Calidi Biotherapeutics Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-8
-7
-5
-5
-5
-5
-5
-4
-4
-4
Operating Cash Flow
-5
-3
-3
-4
-7
-4
-4
-5
-4
-4
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
-2
3
3
6
8
0
9
0
5
1
Change in Cash
-8
0
0
1
0
-5
5
-4
1
-2

Calidi Biotherapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Mar 2025
Dec 2025
Net Income
-7
-10
-25
-29
-22
-20
Operating Cash Flow
-4
-7
-13
-26
-19
-21
Investing Cash Flow
0
0
0
0
0
0
Financing Cash Flow
4
9
12
29
27
17
Change in Cash
0
1
-1
1
7
-3

Global Institutional Holdings in Calidi Biotherapeutics

Check out the Institutions with significant holdings in Calidi Biotherapeutics.

Funds
Holdings
Fidelity Concord Street Trust
1.07%
VANGUARD INDEX FUNDS
0.69%
Vanguard
0.04%
Scott Kapnick
0.03%

Calidi Biotherapeutics News & Key Events

  • img

    Today's Timeline - 17 September

    Thu, 07:05 PM

    -

    Calidi Biotherapeutics announces registered direct offering of 1,025,640 shares at $1.17, expecting gross proceeds of approximately $1.2M.

Insights on Calidi Biotherapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 95.6% return, outperforming this stock by 195.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 637.9% return, outperforming this stock by 733.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, CLDI stock has moved down by -24.2%

About Calidi Biotherapeutics

Calidi Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on immuno-oncology, dedicated to developing advanced immunotherapies for various cancers. The company's innovative approach centers on utilizing powerful, allogeneic (donor-derived) stem cells as specialized carriers for anti-tumor agents. This technology is being advanced to address a range of oncological conditions, including aggressive brain tumors (high-grade gliomas) and other solid malignancies. Calidi's proprietary cell-based delivery systems are expertly designed to safeguard, amplify, and boost the therapeutic effects of oncolytic viruses. This strategic delivery method aims to achieve superior treatment efficacy and enhance patient safety. The company's clinical pipeline features two primary candidates: NeuroNova, which employs allogeneic neural stem cells loaded with an oncolytic adenovirus specifically for the treatment of high-grade gliomas; and SuperNova, which utilizes allogeneic adipose-derived mesenchymal stem cells to deliver the tumor-selective CAL1 oncolytic vaccinia virus for advanced metastatic solid tumors. Established in 2014, Calidi Biotherapeutics operates out of San Diego, California.
OrganisationCalidi Biotherapeutics
Headquarters4475 Executive Drive, San Diego, CA, 92121, US
IndustryBiotechnology
CEOEric E. Poma

Key Management of Calidi Biotherapeutics

Name

Title

Dr. Eric E. Poma Ph.D.

CEO & Director

Mr. Andrew C. Jackson

CFO & Corporate Secretary

Dr. Antonio Fernandez Santidrian Ph.D., Pharm.D.

Head of Technical Operations & Chief Scientific Officer

Dr. Guy Travis Clifton M.D.

Chief Medical Officer

FAQs

What is Calidi Biotherapeutics share price today?

Calidi Biotherapeutics share price today is $1.05 as on at the close of the market. Calidi Biotherapeutics share today touched a day high of $1.12 and a low of $1.00.

What is the 52 week high and 52 week low for Calidi Biotherapeutics share?

Calidi Biotherapeutics share touched a 52 week high of $27.84 on and a 52 week low of $1.00 on . Calidi Biotherapeutics stock price today i.e. is closed at $1.05,which is 96.23% down from its 52 week high and 5.00% up from its 52 week low.

What is Calidi Biotherapeutics's market capitalisation today?

Calidi Biotherapeutics market capitalisation is $0.00T as on .

How to invest in Calidi Biotherapeutics Stock (CLDI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Calidi Biotherapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Calidi Biotherapeutics Stock (CLDI) from India?

Indian investors can start investing in Calidi Biotherapeutics (CLDI) shares with as little as ₹96.292503356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹962.93 in Calidi Biotherapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Calidi Biotherapeutics share’s latest price of $1.05 as on October 6, 2026 at 8:45 am IST, you will get 9.5238 shares of Calidi Biotherapeutics. Learn more about fractional shares .